INSIGHTS ON DRUG DEVELOPMENT
-
![Streamlining drug development]( "Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development")
Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation DevelopmentExplore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.
-
![GettyImages-1133973085-antibody-molecule-immunoglobulin]( "A Tale Of Two Brothers: The Abpro Founders")
A Tale Of Two Brothers: The Abpro FoundersBy founding their latest venture, Abpro, Ian and Eugene Chan are using their synergistic skillsets in business and medicine to rapidly generate antibodies that treat cancer and autoimmune diseases.
-
![getty-1311598658-data-analytics]( "Enabling Quality By Design")
Enabling Quality By DesignOutdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
![GettyImages-1061027852-adenovirus]( "Rapid, Automated, At-Line Adenovirus Quantitation")
Rapid, Automated, At-Line Adenovirus QuantitationGain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.
-
Following The Science To Develop Best-In-Class Cancer Drugs12/11/2023
As innovative cancer therapeutics continue to enter the clinical trial pipeline, some developers are shifting their focus toward developing drugs that are safe and efficacious with minimal toxicity.
-
Rheological Properties Of Pharmaceutical Excipients: Lactose Monohydrate And Carboxymethyl Cellulose12/30/2024
Explore lactose monohydrate and CMC rheology, highlighting their flow, cohesion, and compressibility properties to optimize pharmaceutical formulations under varying stress and temperature conditions.
-
Welcoming The "Era Of ADCs"12/5/2023
Dr. Loretta Itri sat down to explore the promise of TRODELVY®️ and other antibody-drug conjugates as transformative treatments for a range of malignancies and intractable diseases.
-
A Novel Patient-Derived Colorectal Cancer Organoid Platform4/22/2025
Patient-derived organoids are revolutionizing drug discovery by mimicking tumors and predicting therapeutic efficacy. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.
-
Cell Retention Technology And Specialized Cell Culture Media8/11/2025
Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-899692870-lab-cleanroom-research-microscope]( "Peptide Development Strategies")
Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
-
![GettyImages-884796056-solubility-test-pill]( "Pharmaceutical Development")
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.
-
![Scientist standing with SpectraMax iD5e mutlt-mode microplate reader gas mixer included]( "SpectraMax iD3s And iD5e Multi-Mode Microplate Readers")
Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.
The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Programs To Bridge Molecules From Discovery Into Clinical Development")
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
